The target audience is anyone interested in the regulation of market access, pricing and reimbursement of pharmaceuticals and health or medical technologies, in particular:
Physicians, pharmacists and clinical scientists
- in charge of hospitals or hospital departments
- involved (or interested) in health care policy-making
or - clinical trial planning and management
Academics and researchers
- in health economics research departments or institutions
- in health technology assessment (HTA) agencies
- involved (or interested) in producing economic evaluation to inform
policy-makers
Professionals
- in provider units
- in payer organizations
- in the (bio)pharmaceutical, medical device, and related industries
- involved in health care decision-making.
